Recombinant Mycobacterium Tuberculosis Fusion Protein

· Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Recombinant Mycobacterium Tuberculosis Fusion Protein, covering 2024-09-19 to 2025-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above [Phase 3]

See pricing